Original ArticleIndian Journal of Pharmaceutical Education and ResearchVol. 56 | Issue 4 | 2022 | pp. 1044–1051Open access
Formulation Development and Optimization of Famotidine Mucoadhesive Tablets by Central Composite Design
- 1*,
- 1,
- 2,
- 3
- 1 Department of Pharmaceutics, Raghavendra Institute of Pharmaceutical Education and Research, Chiyyedu, Andhra Pradesh, INDIA.
- 2 Department of Industrial Pharmacy, Raghavendra Institute of Pharmaceutical Education and Research, INDIA.
- 3 Department of Pharmacology, Raghavendra Institute of Pharmaceutical Education and Research, INDIA.
Published in Indian Journal of Pharmaceutical Education and Research
Correspondence: Haranath Chinthaginjala
Department of Pharmaceutics, Raghavendra Institute of Pharmaceutical Education and Research, Chiyyedu, Andhra Pradesh, INDIA.
Email: haranathriper@gmail.com
Copyright: © 2022 Manuscript Technomedia. This is an open access article.
- Published:
- Jan 1, 2022
- Received:
- Feb 10, 2022
- Accepted:
- Aug 8, 2022
- DOI:
- 10.5530/ijper.56.4.185
How to cite
Chinthaginjala, H., Telkar, M. B., Hindustan, A. A., & Bhupalam, P. (2022). Formulation Development and Optimization of Famotidine Mucoadhesive Tablets by Central Composite Design. Indian Journal of Pharmaceutical Education and Research, 56(4), 1044–1051. https://doi.org/10.5530/ijper.56.4.185
Abstract
Objectives: The intention of present study is to formulate and optimize the famotidine mucoadhesive tablets y using Central Composite Design. Materials and Methods: The concentrations of Cordia dichotoma fruit mucilage powder (X1) and Polyvinyl pyrrolidone (X2) were demonstrated as independent variables. Whereas, the dependent variables were selected such as an in vitro Mucoadhesion Time and percentage Drug Release. The model was considered to be nonlinear and the curvature effect was significant. Hence, the study reported to Central Composite Design. By using wet granulation method, the tablets were prepared and all the formulated tablets were evaluated for its post compression parameters. Results: The drug and the excipients had no interaction, according to FT-IR and DSC analyses. All formulations showed Mucoadhesion Time ranging from 5 hr to 9 hr and % Drug Release in the range of 96.4% to 99.69%. The association amongst the dependent variable and independent variables was judge by using Contour plots. Conclusion: The outcomes indicated the efficacy of the proposed design for famotidine Mucoadhesive tablets development.
Keywords
Subject
Article metadata
| Title | Formulation Development and Optimization of Famotidine Mucoadhesive Tablets by Central Composite Design |
|---|---|
| Authors | Haranath Chinthaginjala; Mousami Bhavasar Telkar; Abdul Ahad Hindustan; Pradeepkumar Bhupalam |
| Affiliations | Department of Pharmaceutics, Raghavendra Institute of Pharmaceutical Education and Research, Chiyyedu, Andhra Pradesh, INDIA.; Department of Industrial Pharmacy, Raghavendra Institute of Pharmaceutical Education and Research, INDIA.; Department of Pharmacology, Raghavendra Institute of Pharmaceutical Education and Research, INDIA. |
| Corresponding author | haranathriper@gmail.com |
| Journal | Indian Journal of Pharmaceutical Education and Research |
| Volume / Issue | Vol. 56, Issue 4 (2022) |
Also in this issue
- Professional Master of Pharmacy Education in Chinapp. 907–916
- Human Follicular Fluid, Clinical Use of Proteomics Analysis in Identification of Infertilitypp. 917–923
- Recent Advances and Appropriate Use of Niosomes for the Treatment of Skin Cancerpp. 924–937
- Animal Models Alternatives: Desideratum during COVID-19 Pandemicpp. 938–949
- Indian Pharmaceutical Product Protection by Utilizing Intellectual Property Rightspp. 950–958